Sarah Ameen Almofty
Kumamoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sarah Ameen Almofty.
Nature Communications | 2013
Shailendra Kumar Singh; Kazuhiko Maeda; Mohammed Mansour Abbas Eid; Sarah Ameen Almofty; Masaya Ono; Phuong Pham; Myron F. Goodman; Nobuo Sakaguchi
Somatic hypermutation in B cells is initiated by activation-induced cytidine deaminase-catalyzed C→U deamination at immunoglobulin variable regions. Here we investigate the role of the germinal centre-associated nuclear protein (GANP) in enhancing the access of activation-induced cytidine deaminase (AID) to immunoglobulin variable regions. We show that the nuclear export factor GANP is involved in chromatin modification at rearranged immunoglobulin variable loci, and its activity requires a histone acetyltransferase domain. GANP interacts with the transcription stalling protein Spt5 and facilitates RNA Pol-II recruitment to immunoglobulin variable regions. Germinal centre B cells from ganp-transgenic mice showed a higher AID occupancy at the immunoglobulin variable region, whereas B cells from conditional ganp-knockout mice exhibit a lower AID accessibility. These findings suggest that GANP-mediated chromatin modification promotes transcription complex recruitment and positioning at immunoglobulin variable loci to favour AID targeting.
Journal of Immunology | 2014
Mohammed Mansour Abbas Eid; Kazuhiko Maeda; Sarah Ameen Almofty; Shailendra Kumar Singh; Mayuko Shimoda; Nobuo Sakaguchi
RNA export factor germinal center–associated nuclear protein (GANP) interacts with activation-induced cytidine deaminase (AID) and shepherds it from the cytoplasm to the nucleus and toward the IgV region loci in B cells. In this study, we demonstrate a role for GANP in the repair of AID-initiated DNA damage in chicken DT40 B cells to generate IgV region diversity by gene conversion and somatic hypermutation. GANP plays a positive role in IgV region diversification of DT40 B cells in a nonhomologous end joining–proficient state. DNA-PKcs physically interacts with GANP, and this interaction is dissociated by dsDNA breaks induced by a topoisomerase II inhibitor, etoposide, or AID overexpression. GANP affects the choice of DNA repair mechanism in B cells toward homologous recombination rather than nonhomologous end joining repair. Thus, GANP presumably plays a critical role in protection of the rearranged IgV loci by favoring homologous recombination of the DNA breaks under accelerated AID recruitment.
Journal of Immunology | 2013
Kazuhiko Maeda; Sarah Ameen Almofty; Shailendra Kumar Singh; Mohammed Mansour Abbas Eid; Mayuko Shimoda; Terumasa Ikeda; Atsushi Koito; Phuong Pham; Myron F. Goodman; Nobuo Sakaguchi
The ssDNA-dependent deoxycytidine deaminase apolipoprotein B mRNA–editing, enzyme-catalytic, polypeptide-like 3G (A3G) is a potent restrictive factor against HIV-1 virus lacking viral-encoded infectivity factor (Vif) in CD4+ T cells. A3G antiretroviral activity requires its encapsulation into HIV-1 virions. In this study, we show that germinal center–associated nuclear protein (GANP) is induced in activated CD4+ T cells and physically interacts with A3G. Overexpression of GANP augments the A3G encapsidation into the virion-like particles and ΔVif HIV-1 virions. GANP is encapsidated in HIV-1 virion and modulates A3G packaging into the cores together with cellular RNAs, including 7SL RNA, and with unspliced HIV-1 genomic RNA. GANP upregulation leads to a significant increase in A3G-catalyzed G→A hypermutation in the viral genome and suppression of HIV-1 infectivity in a single-round viral infection assay. Conversely, GANP knockdown caused a marked increase in HIV-1 infectivity in a multiple-round infection assay. The data suggest that GANP is a cellular factor that facilitates A3G encapsidation into HIV-1 virions to inhibit viral infectivity.
Stem Cells International | 2018
Firdos Alam Khan; Dana Almohazey; Munthar Alomari; Sarah Ameen Almofty
Human embryonic stem cells (hESCs) hold great potential for the treatment of various degenerative diseases. Pluripotent hESCs have a great ability to undergo unlimited self-renewal in culture and to differentiate into all cell types in the body. The journey of hESC research is not that smooth, as it has faced several challenges which are limited to not only tumor formation and immunorejection but also social, ethical, and political aspects. The isolation of hESCs from the human embryo is considered highly objectionable as it requires the destruction of the human embryo. The issue was debated and discussed in both public and government platforms, which led to banning of hESC research in many countries around the world. The banning has negatively affected the progress of hESC research as many federal governments around the world stopped research funding. Afterward, some countries lifted the ban and allowed the funding in hESC research, but the damage has already been done on the progress of research. Under these unfavorable conditions, still some progress was made to isolate, culture, and characterize hESCs using different strategies. In this review, we have summarized various strategies used to successfully isolate, culture, and characterize hESCs. Finally, hESCs hold a great promise for clinical applications with proper strategies to minimize the teratoma formation and immunorejection and better cell transplantation strategies.
PLOS ONE | 2018
Muhammad Nawaz; Sarah Ameen Almofty; Faiza Qureshi
A hydrothermal method was employed to prepare the sodium niobate (NaNbO3) nanocubes. We executed time dependent experiments to illustrate the formation mechanism of sodium niobate nanocubes. It was observed that the morphology of NaNbO3 nanocubes was dependent on the reaction time and 12hr reaction time was found to be suitable. Morphology, composition, structure and optical properties of sodium niobate nanocubes were evaluated by scanning electron microscope, X-ray energy-dispersive spectrometer, X-ray diffraction and UV-visible diffuse reflectance spectrometer. The photocatalytic activity of sodium niobate was studied for photocatalytic hydrogen production. It was anticipated that the sodium niobate (NaNbO3) cubes exhibited good photocatalytic activity under UV light irradiation using lactic acid as sacrificial agent. The cytotoxicity activity of sodium niobate nanocubes was studied as well at different concentrations (5 mg/mL, 3 mg/mL, 1 mg/mL, and 0.25 mg/mL) against human colon colorectal carcinoma cell line (HCT116) by MTT assay and EC50 was found to be 1.9 mg/mL. Sodium niobate proved to be a good DPPH free radical scavenging material, tested at different concentrations. It was noticed that peak intensity at 517 nm was decreased after 30 minute incubation, further supporting the antioxidant activity. This study will be useful for design and engineering of materials that can be used in biomedical applications and in photocatalysis.
International Journal of Biomaterials | 2018
Firdos Alam Khan; Sultan Akhtar; Dana Almohazey; Munthar Alomari; Sarah Ameen Almofty
Both nanoparticles and cloves (Syzygium aromaticum) possess anticancer properties, but they do not elicit a significant response on cancer cells when treated alone. In the present study, we have tested fluorescent magnetic submicronic polymer nanoparticles (FMSP-nanoparticles) in combination with crude clove extracts on human breast cancer cells (MCF-7) to examine whether the combination approach enhance the cancer cell death. The MCF-7 cells were treated with different concentrations (1.25 μg/mL, 12.5 μg/mL, 50 μg/mL, 75 μg/mL, and 100 μg/mL) of FMSP-nanoparticles alone and in combination with 50 μg/mL crude clove extracts. The effects of FMSP-nanoparticles alone and combined with clove extracts were observed after 24 hrs and 48 hrs intervals. The response of FMSP-nanoparticles-treated cells was evaluated by Trypan Blue, 4′,6-diamidino-2-phenylindole (DAPI), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, respectively. We have demonstrated that cancer cell viability was decreased to 55.40% when treated with FMSP-nanoparticles alone, whereas when cancer cells were treated with FMSP-nanoparticles along with crude clove extracts, the cell viability was drastically decreased to 8.50%. Both morphological and quantitative data suggest that the combination of FMSP-nanoparticles plus crude clove extracts are more effective in treating cancer cells and we suggest that the combination treatment of nanoparticles along with clove extracts hold a great promise for the cancer treatments.
Biomolecules | 2018
Firdos Alam Khan; Sultan Akhtar; Sarah Ameen Almofty; Dana Almohazey; Munthar Alomari
Currently, breast cancer treatment mostly revolves around radiation therapy and surgical interventions, but often these treatments do not provide satisfactory relief to the patients and cause unmanageable side-effects. Nanomaterials show promising results in treating cancer cells and have many advantages such as high biocompatibility, bioavailability and effective therapeutic capabilities. Interestingly, fluorescent magnetic nanoparticles have been used in many biological and diagnostic applications, but there is no report of use of fluorescent magnetic submicronic polymer nanoparticles (FMSP-nanoparticles) in the treatment of human breast cancer cells. In the present study, we tested the effect of FMSP-nanoparticles on human breast cancer cells (MCF-7). We tested different concentrations (1.25, 12.5 and 50 µg/mL) of FMSP-nanoparticles in MCF-7 cells and evaluated the nanoparticles response morphometrically. Our results revealed that FMSP-nanoparticles produced a concentration dependent effect on the cancer cells, a dose of 1.25 µg/mL produced no significant effect on the cancer cell morphology and cell death, whereas dosages of 12.5 and 50 µg/mL resulted in significant nuclear augmentation, disintegration, chromatic condensation followed by dose dependent cell death. Our results demonstrate that FMSP-nanoparticles induce cell death in MCF-7 cells and may be a potential anti-cancer agent for breast cancer treatment.
Artificial Cells Nanomedicine and Biotechnology | 2018
Firdos Alam Khan; Sultan Akhtar; Dana Almohazey; Munthar Alomari; Sarah Ameen Almofty; Abdelhamid Eliassari
Abstract Nanoparticles have many advantages such as high biocompatibility, bioavailability and effective therapeutic capabilities. The aim of the present study is to examine whether fluorescent magnetic submicronic polymer nanoparticles (FMSP-nanoparticles) have any impact on human colorectal cancer cells. In the present study, we have tested FMSP-nanoparticles with an average size of 100–200 nm on human colorectal carcinoma cells (HCT-116) to check their cytotoxic and anti-cancer capabilities. The effects of FMSP-nanoparticles on cancer cells were observed after 6 h, 24 h and 48 h intervals. The response of FMSP-nanoparticles-treated cells was evaluated by Trypan Blue, 4lue-diamidino-2-phenylindole (DAPI) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Our MTT analysis results revealed that FMSP-nanoparticles produced dose-dependent effects on cancer cells, FMSP-nanoparticles with dose of 1.25 µg/mL did not decrease cell survivability, whereas dosages of 12.5 µg/mL and 50 µg/mL respectively showed 23.59% and 59.47% decrease in the cancer cell survivability. In conclusion, our results demonstrate FMSP-nanoparticles have a potential anti-cancer capability and hold a great promise for colon cancer treatments.
International Immunology | 2017
Mohammed Mansour Abbas Eid; Mayuko Shimoda; Shailendra Kumar Singh; Sarah Ameen Almofty; Phuong Pham; Myron F. Goodman; Kazuhiko Maeda; Nobuo Sakaguchi
GANP maintains antibody structural integrity during SHM
European Journal of Integrative Medicine | 2018
Vijaya Ravinayagam; Adeeb Shehzad; Dana Almohazey; Sarah Ameen Almofty; Meneerah Aljafary; Nada A. Alhamed; Najla Alhamed; Noor A. Al-Rashid; Ebtesam A Al-Suhaimi